Physician profile
Michael J Murphy
NPI 1619986510
$839.13
in general payments reported to CMS, 2019-2025
24 companies · $21.70 in 2025
The $21.70 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2020: $60.42 · 2022: $167 · 2024: $31.73 · 2025: $21.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $53.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $53.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $166.94 | 2022 | |
| Lilly USA, LLC | $93.62 | 2019 | |
| Glaxosmithkline, LLC. | $64.30 | 2019-2020 | |
| Novo Nordisk INC | $52.91 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.99 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $39.64 | 2019-2020 | |
| Amgen INC. | $38.82 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.74 | 2019 | |
| Astellas Pharma US INC | $38.06 | 2019-2020 | |
| Abbvie INC. | $34.21 | 2019 | |
| Abbott Laboratories | $31.73 | 2024 | Proclaim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.33 | 2019 | |
| Globus Medical, INC. | $21.70 | 2025 | Senza |
| Ironshore Pharmaceuticals INC. | $15.99 | 2019 | |
| Genentech USA, INC. | $15.02 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $13.16 | 2019 | |
| Dexcom, INC. | $12.79 | 2019 | |
| Pfizer INC. | $12.62 | 2019 | |
| Mylan Specialty L.P. | $12.12 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.86 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.41 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.36 | 2019 | |
| Allergan, INC. | $10.91 | 2019 | |
| Shire North American Group INC | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.